Novo Nordisk A/SNVONYSE
Loading
Operating Income Growth Under PressureDecelerating
Percentile Rank21
3Y CAGR-65.2%
5Y CAGR-17.9%
Year-over-Year Change
Year-over-year operating income growth rate
3Y CAGR
-65.2%/yr
Annual compound
5Y CAGR
-17.9%/yr
Recent deceleration
Percentile
P21
Within normal range
vs 5Y Ago
0.4x
Contraction
Streak
2 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | 1.16% |
| 2024 | 25.12% |
| 2023 | 37.11% |
| 2022 | 27.56% |
| 2021 | 8.35% |
| 2020 | 3.13% |
| 2019 | 11.08% |
| 2018 | -3.51% |
| 2017 | 1.10% |
| 2016 | -2.05% |